Efficient control of pandemic 2009 H1N1 virus infection with intravenous zanamivir despite the lack of immune function

Transplant Infectious Disease

Volumn 14, Issue 6, 2012, Pages 657-659

  Ghosh, S ^a   Adams, O ^a   Schuster, F R ^a   Borkhardt, A ^a   Meisel, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Hematopoietic stem cell transplantation; Pandemic influenza; Zanamivir

Indexed keywords

ANTINEOPLASTIC AGENT; OSELTAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; BONE MARROW APLASIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTOPENIA; NONHUMAN; ORAL MUCOSITIS; PERTUSSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TACHYPNEA; THORAX RADIOGRAPHY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; ZANAMIVIR;

EID: 84870978516     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12004     Document Type: Article

References (11)

1. Bautista E, Chotpitayasunondh T, Gao Z, et al.; Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362 (18): 1708-1719.
2. Espinosa-Aguilar L, Green JS, Forrest GN, et al. Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences. Biol Blood Marrow Transplant 2011; 17 (4): 566-573.
3. George B, Ferguson P, Kerridge I, Gilroy N, Gottlieb D, Hertzberg M. The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2011; 17 (1): 147-153.
4. Rozovski U, Herishanu Y, Gipstein L, Naparstek E. Fatal H1N1 influenza infection in an allo-SCT recipient. Bone Marrow Transplant 2010; 45 (10): 1572-1573.
5. Panning M, Eickmann M, Landt O, et al. Detection of influenza A(H1N1)v virus by real-time RT-PCR. Euro Surveill 2009; 14 (36): pii: 19329.
6. Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010; 362 (1): 88-89.
7. Nguyen HT, Fry AM, Loveless PA, Klimov AI, Gubareva LV. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir. Clin Infect Dis 2010; 51 (8): 983-984.
8. van der Vries E, Stelma FF, Boucher CA. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med 2010; 363 (14): 1381-1382.
9. Fraaij PL, van der Vries E, Beersma MF, et al. Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection. J Infect Dis 2011; 204 (5): 777-782.
10. Dulek DE, Williams JV, Creech CB, et al. Use of intravenous zanamivir after development of oseltamivir resistance in a critically ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis 2010; 50 (11): 1493-1496.
11. Hurt AC, Hardie K, Wilson NJ, et al. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 2011; 365 (26): 2541-2542.